Literature DB >> 21632515

Hydralazine and isosorbide dinitrate in heart failure: historical perspective, mechanisms, and future directions.

Robert T Cole1, Andreas P Kalogeropoulos, Vasiliki V Georgiopoulou, Mihai Gheorghiade, Arshed Quyyumi, Clyde Yancy, Javed Butler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21632515     DOI： 10.1161/CIRCULATIONAHA.110.012781

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  26 in total

1.  Risk factors: Ethnicity and cardiovascular risk-are all men created equal?

Authors:  Carlos G Santos-Gallego; Juan José Badimón
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

2.  Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.

Authors:  Boback Ziaeian; Gregg C Fonarow; Paul A Heidenreich
Journal:  JACC Heart Fail       Date:  2017-07-12       Impact factor: 12.035

Review 3.  Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.

Authors:  Catherine N Marti; Gregg C Fonarow; Stefan D Anker; Clyde Yancy; Muthiah Vaduganathan; Stephen J Greene; Ali Ahmed; James L Januzzi; Mihai Gheorghiade; Gerasimos Filippatos; Javed Butler
Journal:  Eur J Heart Fail       Date:  2018-12-10       Impact factor: 15.534

4.  Models of interinstitutional partnerships between research intensive universities and minority serving institutions (MSI) across the Clinical Translational Science Award (CTSA) consortium.

Authors:  Elizabeth O Ofili; Alecia Fair; Keith Norris; Joseph G Verbalis; Russell Poland; Gordon Bernard; David S Stephens; Steven M Dubinett; Julianne Imperato-McGinley; Robert P Dottin; Jill Pulley; Andrew West; Arleen Brown; Thomas A Mellman
Journal:  Clin Transl Sci       Date:  2013-10-03       Impact factor: 4.689

5.  Peripartum cardiomyopathy: An analysis of clinical profiles and outcomes from a tertiary care centre in southern India.

Authors:  Aditya John Binu; Sudha Jasmine Rajan; Swati Rathore; Manisha Beck; Annie Regi; Viji Samuel Thomson; Sowmya Sathyendra
Journal:  Obstet Med       Date:  2019-06-17

6.  High-density lipoprotein: NO failure in heart failure.

Authors:  Ali Javaheri; Daniel J Rader
Journal:  Circ Res       Date:  2013-12-06       Impact factor: 17.367

7.  Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.

Authors:  Prateeti Khazanie; Li Liang; Lesley H Curtis; Javed Butler; Zubin J Eapen; Paul A Heidenreich; Deepak L Bhatt; Eric D Peterson; Clyde W Yancy; Gregg C Fonarow; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-02       Impact factor: 8.790

8.  Assessing suitability for sacubitril-valsartan therapy in an Irish cohort: challenges and opportunities.

Authors:  Aidan Daly; John J Coughlan; Thomas Mross; Megan Wafer; Aoife O'Connor; Richard Liston
Journal:  Ir J Med Sci       Date:  2019-11       Impact factor: 1.568

9.  Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance.

Authors:  Raul A Dulce; Omer Yiginer; Daniel R Gonzalez; Garrett Goss; Ning Feng; Meizi Zheng; Joshua M Hare
Journal:  J Biol Chem       Date:  2013-01-14       Impact factor: 5.157

Review 10.  The TNF-α/sphingosine-1-phosphate signaling axis drives myogenic responsiveness in heart failure.

Authors:  Jeffrey T Kroetsch; Steffen-Sebastian Bolz
Journal:  J Vasc Res       Date:  2013-04-16       Impact factor: 1.934
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.